Table 3:
HCV genotype/subtype prevalence among different age groups (years) in total 2,153 HCV RNA-positive patients, stratified in two time periods (2001–2005; 2006–2011).
Number of patients (%)
≤25
26–35
36–45
46–55
56–65
>65
Total of age groups
Genotypes/subtypes
2001/05
2006/11
2001/05
2006/11
2001/05
2006/11
2001/05
2006/11
2001/05
2006/11
2001/05
2006/11
2001/05
2006/11
1b
7 (1.1)
9 (2.2)
34 (5.3)
17 (4.1)
35 (5.4)
36 (8.7)
94 (14.5)
48 (11.7)
234 (36.2)
103 (25.0)
243 (37.5)
199 (48.3)
647
412
2a/2c
6 (2.3)
5 (2.2)
7 (2.7)
12 (5.4)
23 (8.9)
8 (3.6)
25 (9.7)
28 (12.5)
82 (31.8)
46 (20.5)
115 (44.6)
125 (55.8)
258
224
3
13 (16.7)
3 (3.7)
23 (29.5)
21 (25.6)
32 (41.0)
35 (42.7)
8 (10.2)
19 (23.2)
1 (1.3)
2 (2.4)
1 (1.3)
2 (2.4)
78
82
4
1 (1.3)
1 (1.7)
8 (10.5)
3 (5.2)
14 (18.4)
16 (27.6)
18 (23.7)
15 (25.9)
24 (31.6)
9 (15.5)
11 (14.5)
14 (24.1)
76
58
1a
1 (3.4)
3 (4.9)
6 (20.7)
11 (18.0)
12 (41.5)
20 (32.8)
5 (17.2)
17 (27.9)
1 (3.4)
6 (9.8)
4 (13.8)
4 (6.6)
29
61
1
*
6 (14.6)
4 (8.2)
11 (26.8)
9 (18.4)
9 (22.0)
6 (12.2)
5 (12.2)
13 (26.5)
10 (24.4)
17 (34.7)
41
49
1a/1b
2 (3.2)
9 (14.5)
23 (37.1)
3 (37.5)
7 (11.3)
3 (37.5)
10 (16.2)
1 (12.5)
11 (17.7)
1 (12.5)
62
8
2
*
1 (2.4)
1 (4.2)
3 (7.3)
6 (25.0)
6 (14.6)
4 (16.6)
8 (19.5)
13 (54.2)
23 (56.2)
24
41
5
2 (100.0)
1 (100.0)
2
1
Total (%)
30 (2.5)
22 (2.4)
93 (7.6)
68 (7.3)
151 (12.4)
130 (13.9)
172 (14.1)
142 (15.2)
361 (29.7)
188 (20.0)
410 (33.7)
386 (41.2)
1217
936
∗
U
nsubtypeable.